MIRA INFORM REPORT

 

 

Report Date :

02.04.2014

 

IDENTIFICATION DETAILS

 

Name :

SIGMA MEDICAL SUPPLIES CORP.

 

 

Registered Office :

No.34, Ding Ping Rd., Ruifang Dist., New Taipei City 224

 

 

Country :

Taiwan

 

 

Date of Incorporation :

21.04.1979

 

 

Com. Reg. No.:

33886753

 

 

Legal Form :

Joint Stock Company

 

 

Line of Business :

Manufacturer and sale of medical supplies

 

 

No of Employees :

About 180

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

No Complaints

 

 

Litigation :

Clear

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – december 01, 2013

 

Country Name

Previous Rating

(30.09.2013)

Current Rating

(01.12.2013)

Taiwan

A2

A2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


 

TAIWAN - ECONOMIC OVERVIEW

 

Taiwan has a dynamic capitalist economy with gradually decreasing government guidance of investment and foreign trade. Exports, led by electronics, machinery, and petrochemicals have provided the primary impetus for economic development. This heavy dependence on exports exposes the economy to fluctuations in world demand. Taiwan's diplomatic isolation, low birth rate, and rapidly aging population are other major long-term challenges. Free trade agreements have proliferated in East Asia over the past several years, and following the landmark Economic Cooperation Framework Agreement (ECFA) signed with China in June 2010, Taiwan in July 2013 signed a free trade deal with New Zealand—Taipei’s first-ever with a country with which it does not maintain diplomatic relations—and in November inked a trade pact with Singapore. Negotiations continue on follow-on components of ECFA regarding trade in goods and a dispute resolution mechanism; a trade in services agreement is under review in the legislature. Taiwan's Total Fertility rate of just over one child per woman is among the lowest in the world, raising the prospect of future labor shortages, falling domestic demand, and declining tax revenues. Taiwan's population is aging quickly, with the number of people over 65 accounting for 11.2% of the island's total population as of 2012. The island runs a large overall trade surplus largely because of its surplus with China, and its foreign reserves are the world's sixth largest, behind China, Japan, Saudi Arabia, Russia, and Switzerland. In 2006 China overtook the US to become Taiwan's second-largest source of imports after Japan. China is also the island's number one destination for foreign direct investment. Taiwan since 2009 has gradually loosened rules governing Chinese investment on the island, and has also secured greater market access for its investors in the mainland. In August 2012, Taiwan Central Bank signed a memorandum of understanding on cross-Strait currency settlement with its Chinese counterpart. The MOU allows for the direct settlement of Chinese RMB and the New Taiwan dollar across the Strait, which could help develop Taiwan into a local RMB hub. Closer economic links with the mainland bring greater opportunities for the Taiwan economy, but also poses new challenges as the island becomes more economically dependent on China while political differences remain unresolved.

 

Source : CIA

 


Contact Points

 

Company Name:

Sigma Medical Supplies Corp.

Supplied Name:

SIGMA MEDICAL SUPPLIES CORP.

Trading Address:

No.34, Ding Ping Rd., Ruifang Dist., New Taipei City 224, Taiwan (R.O.C.)

Supplied Address:

2FL., NO. 19, LANE 97, SEC. 1, HSIN -SHENG S. RD., TAIPEI 10652 Taiwan

Telephone Number:

+886-2-2497-4121

Fax Number:

+886-2-2497-4122

Notes: Subject’s exact address is as above.

 

Credit Summary

 

Credit Opinion:

Business connections are permissible.

 

Company Identification Details

 

Registered Name:

Sigma Medical Supplies Corp.

Registered Address:

No.34, Ding Ping Rd., Ruifang Dist., New Taipei City 224, Taiwan (R.O.C.)

Date of Foundation:

1979-4-21

Registration Number:

33886753

Registry:

New Taipei City Government

Registered Capital:

NTD 170,000,000 (USD 5,593,000)

(As of 2014.03, 1 NTD = 0.0329 USD)

Paid-up Capital:

NTD 130,000,000 (USD 4,277,000)

Legal Representatives:

Shengzhi Wang

Legal Form:

Joint Stock Company

Principal Activities:

Manufacturing and sale of medical supplies, etc.

Staff:

About 180 Employees

Listed at Stock Exchange:

No

Date of Last Annual Return:

2014-3-11

 

History

 

Subject was incorporated on 1979-4-21 with registered number 33886753 as Joint Stock Company in Taiwan.

 

Shareholders

 

Name

Subscription Shares

Shantai Technology Corp. (Literal Translation)

10,000 

Taipoly Industries Corporation

10,000

Nsh Medical Corp.

2,822,827

Yijie Zhu

1,050,847

 

The information above is that of subject’s major shareholders.

 

Shareholder Information:

 

1

Name:

Shantai Technology Corp. (Literal Translation)

Address:

No. 261, Sanjia East Street, Beitun Dist., Taichung City, Taiwan

Legal Form:

Joint Stock Company

Tel:

+886- 4-2436-6111

Fax:

+886-4-2436-3202

Principle Activities:

Manufacturing and sale of electronics, etc.

Staff:

About 400 Employees

Listed at Stock Exchange:

No

2

Registered Name:

Taipoly Industries Corporation

Registered Address:

No.36, Industrial 24th Rd., Taichung, Taiwan, R.O.C.

Legal Form:

Joint Stock Company

Legal Representative:

Shengzhi Wang

Principal Activities:

Manufacturing and sale of packaging materials, etc.

Tel:

+886-4-2359-0161

Fax:

+886-4-2350-9510

Staff:

About 185 Employees

Listed at Stock Exchange:

No

Date of Last Annual Return:

2014-3-10

3

Registered Name:

Nsh Medical Corp.

Registered Address:

2F. No.19, lane 97, Sec.1, Shin Sheng S. Rd., Taipei, Taiwan, R.O.C.

Legal Form:

Joint Stock Company

Legal Representative:

Zhennan Zhu

Principal Activities:

Manufacturing and sale of medical equipment, etc.

Tel:

+886-2-2721-0166

Fax:

+886-2-2777-4201

Staff:

About 26 Employees

Listed at Stock Exchange:

No

Date of Last Annual Return:

2013-2-4

 

Subsidiaries & Branches

 

Factory

 

Address:

No.34, Ding Ping Rd., Ruifang Dist., New Taipei City 224, Taiwan (R.O.C.)

Date of Foundation:

1997-6-2

Date of Registration:

1997-8-12

Factory Registration Number:

99601363

Factory Manager:

Shengxun Zhu

Status:

In production

Date of Last Annual Return:

2013-7-31

Major Products:

332 medical equipment & product

220 plasthetics

 

Personnel Information

 

Core Management

 

Directors

1

Name

Shengzhi Wang

Position

Director

2

Name

Yifen Pan

Position

Director

3

Name

Wenhai Zeng

Position

Director

4

Name

Mingqing Huang

Position

Director

5

Name

Nsh Medical Corp.

Position

Director

6

Name

Yongjia Zhuang

Position

Supervisor

7

Name

Yijie Zhu

Position

Supervisor

 

Personnel Structure

 

Total Employees

About 180 Employees

 

Operation Information

 

Offices & Factories

 

 

Headquarters

Add

No.34, Ding Ping Rd., Ruifang Dist., New Taipei City 224, Taiwan

 

Production Information

 

l  Subject is engaged in manufacturing of medical supplies, etc.

l  Subject has a factory in Taiwan for production.

 

Purchase Information

 

l  The registered activities of subject:

 

Details

1

Manufacturing and trading of medical equipment, etc.

2

Import of materials for manufacturing of medical equipment

3

Import and distribution of foreign medical equipment

 

l  The components and raw materials for production are both purchased at home and abroad like Europe, Japan, and USA, etc.

 

Sales Information

 

l  Subject is engaged in sale of medical supplies, etc.

l  The major products sold by subject include sterilization packaging & products like crepe paper wraps, nonwoven warps, flat sterilization rolls, sterilization rolls, self-sealing sterilization pouches, header bags, easy-peel pouches, steam sterilization indicator tapes, etc.

l  Subject’s sales regions include domestic market, Japan, Korea, Southeast Asia, USA, Europe, etc.

l  Subject’s major customers are hospitals, clinics and drug stores, etc.

Import and export right:

 

Import right

Yes

Export right

Yes

 

Settlements

 

Purchase

 

Domestic Purchase

Product

Terms

Proportion

Components and raw materials, etc.

T/T, Cash, etc

100%

 

Foreign Purchase

Product

Terms

Proportion

Components and raw materials, etc.

L/C, T/T, etc

100%

 

Sales

 

Domestic Markets

Product

Terms

Proportion

Medical supplies, etc.

T/T, Cash, etc

100%

 

Export

Product

Terms

Proportion

Medical supplies, etc.

L/C, T/T, etc

100%

 

 

 

Financial Information

 

Subject has no obligations to disclose its financial statements to the third party according to the relevant policy in Taiwan and the only source from which we can obtain the information is the subject itself.

Subject’s relevant staff declined to disclose its financials citing the grounds of company’s confidentiality; from other source we cannot obtain the relevant information, either.

 

Bankers

 

Name:

 Chang Hwa Bank

 

Public Record

 

Mortgage

 

No chattel mortgage record of subject has been found within the recent 3 months.

 

Lawsuit

 

Trial Number:

101, Beijian, 10259

Date of Trial:

2012-8-6

Reason:

Increase payment

Claimant:

Sigma Medical Supplies Corp.

Defendant:

Executive Council Chinese Officers And Soldiers Back Discharged Committee

 

Interview Details

 

Name

Mr. Wang

Department

Sales

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs. 60.09

UK Pound

1

Rs. 99.84

Euro

1

Rs. 82.57

 

 

INFORMATION DETAILS

 

Analysis Done by :

SMT

 

 

Report Prepared by :

DPT

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.